Research map: Management of hyperkalaemia in the Italian clinical practice: impact of diverse potassium binders on outcomes and costs in patients with chronic kidney disease and heart failure

Back to the article

Papers in this map

  1. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation · Mary E. Charlson · 1987 · 50679 citations · Cited by this paper
  2. Machine learning–based prediction of Clavien–Dindo ≥ II complications after ureteroscopy · 2026 · Related
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Paul E. Stevens · 2024 · 8239 citations · Cited by this paper
  4. Micropapillary variant of upper tract urothelial carcinoma: a SEER-based propensity score–matched analysis of clinicopathological features and survival outcomes · 2026 · Related
  5. Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors · Matthew R. Weir · 2014 · 676 citations · Cited by this paper
  6. Kidney transplantation outcomes in recipients with end-stage kidney disease due to primary vesicoureteral reflux: a case-control study · 2026 · Related
  7. Sodium Zirconium Cyclosilicate in Hyperkalemia · David Packham · 2014 · 505 citations · Cited by this paper
  8. Nocturnal enuresis in children with allergic disease: prevalence, phenotype, and ARIA severity analysis · 2026 · Related
  9. Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia · Mikhail Kosiborod · 2014 · 411 citations · Cited by this paper
  10. Association between 24-h proteinuria and phenotypic age acceleration in adults with preserved kidney function: a cross-sectional study · 2026 · Related
  11. Gastrointestinal Adverse Events with Sodium Polystyrene Sulfonate (Kayexalate) Use: A Systematic Review · Ziv Harel · 2013 · 325 citations · Cited by this paper
  12. Brief review: heart failure as a hemodynamic consequence of high-flow arteriovenous fistulas among end-stage kidney disease patients on hemodialysis · 2026 · Related
  13. Ion-Exchange Resins for the Treatment of Hyperkalemia · Richard H. Sterns · 2010 · 303 citations · Cited by this paper
  14. Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation · 2026 · Related
  15. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease · Iris E. Beldhuis · 2022 · 216 citations · Cited by this paper
  16. Maintenance of Serum Potassium with Sodium Zirconium Cyclosilicate (ZS-9) in Heart Failure Patients: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial · Stefan D. Anker · 2015 · 182 citations · Cited by this paper
  17. Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term Registry · Patrick Rossignol · 2020 · 154 citations · Cited by this paper
  18. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age · J. Ariana Noel · 2019 · 153 citations · Cited by this paper
  19. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia · Steven N. Fishbane · 2019 · 148 citations · Cited by this paper
  20. Treatment of hyperkalemia: something old, something new · Richard H. Sterns · 2016 · 141 citations · Cited by this paper
  21. Potassium Binders for Hyperkalemia in Chronic Kidney Disease—Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis · Biff F. Palmer · 2019 · 113 citations · Cited by this paper
  22. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes—a Danish population-based cohort study · Reimar Wernich Thomsen · 2017 · 98 citations · Cited by this paper
  23. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Hyperkalaemia: The Randomized, Placebo-Controlled HARMONIZE-Global Study · Faiez M. Zannad · 2020 · 76 citations · Cited by this paper
  24. Long-Term Effects of Patiromer for Hyperkalaemia Treatment in Patients with Mild Heart Failure and Diabetic Nephropathy on Angiotensin-Converting Enzymes/Angiotensin Receptor Blockers: Results from AMETHYST-DN · Bertram Pitt · 2018 · 59 citations · Cited by this paper
  25. Effects of Hyperkalaemia and Non-Adherence to Renin–Angiotensin–Aldosterone System Inhibitor Therapy in Patients with Heart Failure in Italy: A Propensity-Matched Study · Maurizio Volterrani · 2020 · 52 citations · Cited by this paper
  26. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines · Luis Antonio Alcocer · 2023 · 50 citations · Cited by this paper
  27. The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland · Thomas T. Ward · 2022 · 32 citations · Cited by this paper
  28. Management of RAASi-associated hyperkalemia in patients with cardiovascular disease · José Silva‐Cardoso · 2021 · 31 citations · Cited by this paper
  29. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer · Min Zhuo · 2022 · 29 citations · Cited by this paper
  30. Treatment of Hyperkalemia in Heart Failure · Ersilia M. DeFilippis · 2017 · 22 citations · Cited by this paper
  31. The Association of Heart Failure and Edema Events between Patients Initiating Sodium Zirconium Cyclosilicate or Patiromer · Nihar R. Desai · 2024 · 16 citations · Cited by this paper
  32. Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC) · Ali AlSahow · 2023 · 14 citations · Cited by this paper
  33. Experience with the Potassium Binder Patiromer in Hyperkalaemia Management in Heart Failure Patients in Real Life · Alberto Esteban‐Fernández · 2022 · 13 citations · Cited by this paper
  34. Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences · Raúl Fernández-Prado · 2023 · 13 citations · Cited by this paper
  35. Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care · Sascha van Boemmel-Wegmann · 2024 · 11 citations · Cited by this paper
  36. Hyperkalemia management: a multidisciplinary expert panel’s perspective on the role of new potassium binders · Cândida Fonseca · 2024 · 11 citations · Cited by this paper
  37. EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart Failure · Natalie P. Kreitzer · 2025 · 10 citations · Cited by this paper
  38. Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis · Siqi Yang · 2024 · 8 citations · Cited by this paper
  39. Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN · Rajkumar Chinnadurai · 2023 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)